HCABy Calypso Research5 min read

HCA Healthcare (HCA) Q4 2025 Earnings Analysis

Healing Growth with $19.5B in Revenue Boost

Key Takeaways

HCA Healthcare (HCA) reported Q4 2025 earnings with revenue of $19.5B, representing a +6.7% year-over-year change. The stock moved +7.1% on earnings day.

The bull case: HCA’s investments in AI, outpatient expansion, and resiliency programs position it for sustained growth and margin stability despite near-term headwinds.

The bear case: ACA subsidy expiration and supplemental payment declines will pressure volumes and margins, creating uncertainty around long-term profitability.

Financial Highlights

  • Revenue: $19.5B (+6.7% YoY)
  • Gross Profit: $8.2B (41.9% margin, +0.5% YoY)
  • Operating Income: $3.2B (16.3% margin, +0.7% YoY)
  • Net Income: $1.9B
  • TTM Revenue: $75.6B

Stock Performance

  • Earnings Day Move: +7.1%
  • Year-to-Date: +13.9%
  • 1-Year Return: +67.7%
  • vs. S&P 500 (since earnings): +6.8%
  • vs. Nasdaq (since earnings): +8.7%

View live HCA data, AI chat, and interactive debates on Calypso →

What Management Said

Here are the key debates and direct quotes from HCA Healthcare's Q4 2025 earnings call:

Impact of ACA Subsidy Expiration and Exchange Headwinds on 2026 Guidance

Sentiment: Negative

"We contemplate a 15% to 20% decline in our Hicks volumes in 2026. Of the decline in our volume, we assume approximately 15% to 20% will move to employee-sponsored coverage, which carries a benefit, with the remaining migrating to uninsured." — Mike Hart
"The $600 to $900 million adverse impact to EBITDA includes the expiration of enhanced premium tax credits, and our model assumes a decline in utilization from uninsured individuals of approximately 30% compared to when they had coverage." — Mike Hart

Execution and Confidence in $400 Million Resiliency Program for 2026

Sentiment: Positive

"The $400 million in savings will come from four focus areas: revenue integrity, variable and fixed cost efficiencies, and capacity management. These efforts are bolstered by AI, automation, and shared service platforms." — Mike Hart
"This is not an episodic event for us. It’s a cultural dynamic around being cost-effective and leveraging scale, best practices, and transparency." — Samuel Hazen

Strategic Investments in Digital Transformation and Artificial Intelligence

Sentiment: Positive

"We are investing heavily in three domains: administrative efficiencies, operational improvements, and clinical enhancements, with AI playing a foundational role in each area." — Samuel Hazen
"We see AI as a tool to help physicians make better decisions, improve nurse workflows, and enhance patient safety." — Samuel Hazen

Payer Mix Dynamics and Medicaid Supplemental Payment Adjustments

Sentiment: Mixed

"We anticipate a $250 to $450 million decline in net benefit from state supplemental payments, driven by the pause in Texas’ Atlas program and the reversion of Tennessee’s program to four quarters." — Mike Hart
"Medicaid grew 2.2% year-over-year despite redetermination impacts, reflecting a normalization in its growth rate." — Mike Hart

Growth in Outpatient Investments and Strategy

Sentiment: Positive

"We added roughly 100 outpatient business units this past year and see outpatient revenue as a growing percentage of our total revenue." — Samuel Hazen
"Our target is 18 to 20 outpatient facilities per hospital by the end of the decade through a mix of Greenfield projects and acquisitions." — Samuel Hazen

Bull Case

HCA’s investments in AI, outpatient expansion, and resiliency programs position it for sustained growth and margin stability despite near-term headwinds.

Bear Case

ACA subsidy expiration and supplemental payment declines will pressure volumes and margins, creating uncertainty around long-term profitability.

Looking Ahead

Investors will be closely watching HCA Healthcare's next quarterly report for continued execution, particularly around impact of ACA Subsidy Expiration and Exchange Headwinds on 2026 Guidance. With operating margins at 16.3%, margin trends will remain a focal point. The market's positive reaction on earnings day suggests confidence in management's direction, and the next earnings report will be a key catalyst for the stock.

Frequently Asked Questions

What was HCA Healthcare's revenue in Q4 2025?

HCA Healthcare reported Q4 2025 revenue of $19.5B, representing a +6.7% year-over-year change.

Did HCA Healthcare beat earnings expectations in Q4 2025?

The stock rose +7.1% on earnings day, suggesting the results met or exceeded market expectations. The current bull case centers on: HCA’s investments in AI, outpatient expansion, and resiliency programs position it for sustained growth and margin stability despite near-term headwinds.

What is the bull case for HCA stock?

The bull case for HCA centers on: HCA’s investments in AI, outpatient expansion, and resiliency programs position it for sustained growth and margin stability despite near-term headwinds.

What is the bear case for HCA stock?

The bear case for HCA centers on: ACA subsidy expiration and supplemental payment declines will pressure volumes and margins, creating uncertainty around long-term profitability.

How has HCA stock performed since its Q4 2025 earnings?

HCA moved +7.1% on the day of its Q4 2025 earnings report, outperforming the S&P 500 by +6.8% since earnings. Year-to-date, the stock has returned +13.9%.

View all Healthcare Earnings Reports →

Browse all 400+ earnings reports →

Learn More

Analyze HCA in Real Time

This is a static snapshot. For live financial data, AI-powered chat, and interactive earnings debates for HCA Healthcare and 400+ other stocks, explore the full platform.

Open HCA on Calypso →

Calypso is an AI-powered equity research platform used by investment teams to cut earnings research time by over 80%.